+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Oxygen Delivery Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 283 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6071371
The global market for Respiratory Oxygen Delivery Devices was valued at US$14 Billion in 2025 and is projected to reach US$22 Billion by 2032, growing at a CAGR of 6.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Respiratory Oxygen Delivery Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Respiratory Oxygen Delivery Devices Increasing?

Respiratory oxygen delivery devices have become essential for managing acute and chronic respiratory conditions, including COPD, asthma, and pneumonia. The rising prevalence of respiratory diseases, coupled with aging populations and increasing healthcare accessibility, has fueled demand for high-efficiency oxygen therapy solutions. Hospitals, emergency care units, and home healthcare providers rely on oxygen delivery devices such as nasal cannulas, oxygen masks, and non-invasive ventilators to support patients with breathing difficulties. The surge in demand during the COVID-19 pandemic further highlighted the critical role of oxygen therapy in healthcare systems, leading to increased investment in oxygen supply infrastructure and portable oxygen concentrators.

How Are Technological Innovations Transforming Oxygen Delivery Devices?

Advancements in portable oxygen concentrators, high-flow nasal cannulas, and non-invasive ventilation systems have improved the efficiency and convenience of respiratory oxygen therapy. Smart oxygen delivery systems with real-time oxygen saturation monitoring and AI-driven flow adjustments are enhancing patient outcomes. Additionally, miniaturized and battery-powered oxygen concentrators are providing greater mobility for patients requiring long-term oxygen therapy. Innovations in humidified oxygen therapy have also improved patient comfort, reducing nasal dryness and irritation. These technological improvements are making respiratory oxygen delivery more accessible, efficient, and patient-friendly.

What Market Trends Are Influencing the Growth of Oxygen Delivery Devices?

The increasing preference for home-based respiratory care has driven demand for portable oxygen devices, reducing dependence on hospital-based oxygen therapy. Additionally, the rise of telemedicine and remote patient monitoring has enhanced the management of chronic respiratory conditions, enabling real-time oxygen therapy adjustments. The integration of digital health solutions with oxygen delivery devices is also improving patient compliance and treatment efficacy. Furthermore, the expansion of healthcare infrastructure in developing regions has increased the availability of oxygen therapy in underserved areas.

What Are the Key Growth Drivers of the Respiratory Oxygen Delivery Devices Market?

The growth in the global respiratory oxygen delivery devices market is driven by rising respiratory disease prevalence, advancements in oxygen therapy technology, and increasing demand for portable and home-based oxygen solutions. Government initiatives aimed at improving healthcare access and oxygen supply chains have further supported market expansion. Additionally, the development of smart respiratory devices with AI-based monitoring capabilities is enhancing treatment personalization. As global healthcare systems continue to prioritize respiratory health, the market for oxygen delivery devices is expected to experience sustained growth, driven by ongoing innovation and expanding healthcare accessibility.

Report Scope

The report analyzes the Respiratory Oxygen Delivery Devices market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others); End-Use (Hospitals, Outpatient Facilities, Home Care).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Oxygen Masks segment, which is expected to reach US$6.1 Billion by 2032 with a CAGR of a 5.7%. The Nasal Cannula segment is also set to grow at 5.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $3.8 Billion in 2025, and China, forecasted to grow at an impressive 9.9% CAGR to reach $4.6 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Respiratory Oxygen Delivery Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Respiratory Oxygen Delivery Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Respiratory Oxygen Delivery Devices Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Air Liquide S.A., Becton, Dickinson and Company, Besmed Health Business Corp., CAIRE Inc., Drägerwerk AG & Co. KGaA and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Respiratory Oxygen Delivery Devices market report include:

  • Air Liquide S.A.
  • Becton, Dickinson and Company
  • Besmed Health Business Corp.
  • CAIRE Inc.
  • Drägerwerk AG & Co. KGaA
  • Drive DeVilbiss Healthcare
  • Fisher & Paykel Healthcare Limited
  • Flexicare Medical Limited
  • GCE Group
  • GE HealthCare Technologies Inc.
  • Inogen, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Lincare Holdings Inc.
  • Masimo Corporation
  • Medline Industries, LP
  • Medtronic plc
  • Norco Inc.
  • OMRON Healthcare
  • PARI GmbH

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Air Liquide S.A.
  • Becton, Dickinson and Company
  • Besmed Health Business Corp.
  • CAIRE Inc.
  • Drägerwerk AG & Co. KGaA
  • Drive DeVilbiss Healthcare
  • Fisher & Paykel Healthcare Limited
  • Flexicare Medical Limited
  • GCE Group
  • GE HealthCare Technologies Inc.
  • Inogen, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Lincare Holdings Inc.
  • Masimo Corporation
  • Medline Industries, LP
  • Medtronic plc
  • Norco Inc.
  • OMRON Healthcare
  • PARI GmbH

Table Information